Detailed answers about CHALGROVE PHARMACY LTD, including incorporation, status, business activity, and accounts information.
When was CHALGROVE PHARMACY LTD founded?
CHALGROVE PHARMACY LTD was officially incorporated on 24 November 2000 and is registered under company number 04114533. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CHALGROVE PHARMACY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CHALGROVE PHARMACY LTD?
CHALGROVE PHARMACY LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CHALGROVE PHARMACY LTD do?
CHALGROVE PHARMACY LTD operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is CHALGROVE PHARMACY LTD's registered address?
The registered office address of CHALGROVE PHARMACY LTD is 60 HIGH STREET, CHALGROVE, OXFORD, ENGLAND, OX44 7SS. This is the official address filed with Companies House for legal and statutory correspondence.
Is CHALGROVE PHARMACY LTD financially stable?
The most recent accounts for CHALGROVE PHARMACY LTD were made up to 31 July 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 April 2027.
Does CHALGROVE PHARMACY LTD have any charges or mortgages?
CHALGROVE PHARMACY LTD has 11 registered charges, of which 4 are outstanding, 7 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.